Effect of Radial Shockwave Therapy and Graston Instrument Assisted Soft Tissue Mobilization on Plantar Fasciitis
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 19, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different treatments for plantar fasciitis, a common condition that causes pain in the heel due to inflammation of a tissue band on the bottom of the foot. The study is comparing Radial Shockwave Therapy (RST), which is a non-invasive treatment that helps stimulate healing, and Graston Instrument-Assisted Soft Tissue Mobilization (IASTM), which involves using special tools to help relieve pain and improve movement. The goal is to find out which method is more effective in relieving symptoms for people suffering from this condition.
To participate in the trial, individuals must be between the ages of 20 and 45 and have been experiencing heel pain for more than three months. They should feel a sharp pain in the bottom of their heel, especially when they first get up in the morning or after sitting for a long time. However, those with certain other foot problems, previous surgeries, or specific medical conditions will not be eligible to join. Participants can expect to receive one of the two treatments and will be monitored for their progress. This study is currently recruiting participants, and it offers a chance to try a new approach to managing heel pain without resorting to surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both genders (male/female) Age 20 to 45 (25) unilateral chronic plantar fasciitis of more than 3 months Pre diagnosed with chronic plantar fasciitis soreness and local tenderness bottom of the heel. Searing or piercing type pain (26) Pain greater than four on the visual analogue scale (VAS) during the first steps in the morning(10) gradual development of pain with no trauma(27) pain generated by local pressure(26) Increase in pain in the morning upon taking a few steps or after prolonged non-weight bearing(28) symptoms decreasing with slight levels of activity, such as walking(11) No previous history of radial shockwave therapy or Graston technique for plantar fasciitis
- Exclusion Criteria:
- • - Having lower limb pathology (24) Tarsal tunnel syndrome (TTS) Fat-pad syndrome(11) Have heel spurs(26) Bilateral PF Previous ankle or foot surgery History of topical corticosteroid injections to the ankle or foot Neuropathic or radicular pain in the lower limbs Participants with systemic diseases that cause foot discomfort, such as ankylosing spondylitis, osteoporosis psoriatic arthritis, rheumatoid arthritis, and gout, foot bursitis, as well as those with type I or type II diabetes and pregnancy, were also excluded from the study.(25)
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
SABA RAFIQUE, MsPT(OMPT)
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported